ArticleIn vivo (Athens, Greece)

Docetaxel Rechallenge Improves Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study.

Sheng-Chun Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.